Economic development officials in Baltimore are fretting that they're one step behind the pace being set in Montgomery County, where low-cost lab space along with offers of small loans and grants have been luring away emerging drug developers. In the case of Amulet Pharmaceuticals, a spinoff of Johns Hopkins, a $25,000 loan and some free PR proved too much to ignore.
It's a big issue for Baltimore, which has two new bioparks to fill. One particularly thorny issue, according to the Baltimore Business Journal, is getting the city of Baltimore to work as a team with the county. Another key will be in coming up with competitive lease rates for developers in need of lab space.
- read the article in the Baltimore Business Journal
Top Five Regions Targeting Biotech Companies - 2008